Review Article| Volume 50, ISSUE 1, P89-99, March 2023

Magnesium Sulfate Use in Pregnancy for Preeclampsia Prophylaxis and Fetal Neuroprotection

Regimens in High-Income and Low/Middle-Income Countries
  • Kathleen F. Brookfield
    Corresponding author. Department of Obstetrics and Gynecology, Oregon Health & Science University, 3181 Southwest Sam Jackson Park Road, Portland, OR 97239.
    Department of Obstetrics and Gynecology, Oregon Health & Science University, 3181 Southwest Sam Jackson Park Road, Portland, OR 97239, USA

    Legacy Medical Group, Maternal Fetal Medicine, Legacy Health System, Portland, OR, USA
    Search for articles by this author
  • Osinakachukwu Mbata
    Department of Obstetrics and Gynecology, Oregon Health & Science University, 3181 Southwest Sam Jackson Park Road, Portland, OR 97239, USA
    Search for articles by this author


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.


      Subscribe to Obstetrics and Gynecology Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • American College of Obstetricians and Gynecologists Committee on Obstetric Practice Society for Maternal-Fetal Medicine
        Committee Opinion No. 573: magnesium sulfate use in obstetrics.
        Obstet Gynecol. 2013; 122: 727-728
        • Crowther C.A.
        • Hiller J.E.
        • Doyle L.W.
        • et al.
        Australasian Collaborative Trial of Magnesium Sulphate Collaborative G. Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial.
        JAMA. 2003; 290: 2669-2676
        • Marret S.
        • Marpeau L.
        • Zupan-Simunek V.
        • et al.
        Magnesium sulphate given before very-preterm birth to protect infant brain: the randomised controlled PREMAG trial.
        BJOG. 2007; 114: 310-318
        • Rouse D.J.
        • Hirtz D.G.
        • Thom E.
        • et al.
        A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy.
        N Engl J Med. 2008; 359: 895-905
        • Pritchard J.A.
        The use of the magnesium ion in the management of eclamptogenic toxemias.
        Surg Gynecol Obstet. 1955; 100: 131-140
        • Tang J.
        • He A.
        • Li N.
        • et al.
        Magnesium Sulfate-Mediated Vascular Relaxation and Calcium Channel Activity in Placental Vessels Different From Nonplacental Vessels.
        J Am Heart Assoc. 2018; 7
        • Sibai B.M.
        • Spinnato J.A.
        • Watson D.L.
        • et al.
        Effect of magnesium sulfate on electroencephalographic findings in preeclampsia-eclampsia.
        Obstet Gynecol. 1984; 64: 261-266
        • Lu J.
        • Pfister M.
        • Ferrari P.
        • et al.
        Pharmacokinetic-pharmacodynamic modelling of magnesium plasma concentration and blood pressure in preeclamptic women.
        Clin Pharmacokinet. 2002; 41: 1105-1113
        • Brookfield K.F.
        • Su F.
        • Elkomy M.H.
        • et al.
        Pharmacokinetics and placental transfer of magnesium sulfate in pregnant women.
        Am J Obstet Gynecol. 2016; 214: 737 e1-e9
        • Chuan F.S.
        • Charles B.G.
        • Boyle R.K.
        • et al.
        Population pharmacokinetics of magnesium in preeclampsia.
        Am J Obstet Gynecol. 2001; 185: 593-599
        • Salinger D.H.
        • Mundle S.
        • Regi A.
        • et al.
        Magnesium sulphate for prevention of eclampsia: are intramuscular and intravenous regimens equivalent? A population pharmacokinetic study.
        BJOG. 2013; 120: 894-900
        • Du L.
        • Wenning L.
        • Migoya E.
        • et al.
        Population Pharmacokinetic Modeling to Evaluate Standard Magnesium Sulfate Treatments and Alternative Dosing Regimens for Women With Preeclampsia.
        J Clin Pharmacol. 2019; 59: 374-385
        • da Costa T.X.
        • Azeredo F.J.
        • Ururahy M.A.G.
        • et al.
        Population pharmacokinetics of magnesium sulfate in preeclampsia and associated factors.
        Drugs R D. 2020; 20: 257-266
        • Brookfield K.F.
        • Elkomy M.
        • Su F.
        • et al.
        Optimization of maternal magnesium sulfate administration for fetal neuroprotection: application of a prospectively constructed pharmacokinetic model to the BEAM cohort.
        J Clin Pharmacol. 2017; 57: 1419-1424
        • Du L.
        • Wenning L.A.
        • Carvalho B.
        • et al.
        Alternative magnesium sulfate dosing regimens for women with preeclampsia: a population pharmacokinetic exposure-response modeling and simulation study.
        J Clin Pharmacol. 2019; 59: 1519-1526
        • Okusanya B.O.
        • Oladapo O.T.
        • Long Q.
        • et al.
        Clinical pharmacokinetic properties of magnesium sulphate in women with pre-eclampsia and eclampsia.
        BJOG. 2016; 123: 356-366
        • Chesley L.C.
        • Tepper I.
        Plasma levels of magnesium attained in magnesium sulfate therapy for preeclampsia and eclampsia.
        Surg Clin North Am. 1957; 37: 353-367
        • Sibai B.M.
        • Lipshitz J.
        • Anderson G.D.
        • et al.
        Reassessment of intravenous MgSO4 therapy in preeclampsia-eclampsia.
        Obstet Gynecol. 1981; 57: 199-202
        • Smith J.M.
        • Lowe R.F.
        • Fullerton J.
        • et al.
        An integrative review of the side effects related to the use of magnesium sulfate for pre-eclampsia and eclampsia management.
        BMC Pregnancy Childbirth. 2013; 13: 34
        • Nick J.M.
        Deep tendon reflexes, magnesium, and calcium: assessments and implications.
        J Obstet Gynecol Neonatal Nurs. 2004; 33: 221-230
        • Duley L.
        • Gulmezoglu A.M.
        • Henderson-Smart D.J.
        • et al.
        Magnesium sulphate and other anticonvulsants for women with pre-eclampsia.
        Cochrane Database Syst Rev. 2010; 10: CD000025
      1. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial.
        Lancet. 2002; 359: 1877-1890
        • Lu J.F.
        • Nightingale C.H.
        Magnesium sulfate in eclampsia and pre-eclampsia: pharmacokinetic principles.
        Clin Pharmacokinet. 2000; 38: 305-314
        • Sibai B.M.
        • Graham J.M.
        • McCubbin J.H.
        A comparison of intravenous and intramuscular magnesium sulfate regimens in preeclampsia.
        Am J Obstet Gynecol. 1984; 150: 728-733
        • Abbade J.F.
        • Costa R.A.
        • Martins A.M.
        • et al.
        Zuspan's scheme versus an alternative magnesium sulfate scheme: Randomized clinical trial of magnesium serum concentrations.
        Hypertens Pregnancy. 2010; 29: 82-92
        • Guzin K.
        • Goynumer G.
        • Gokdagli F.
        • et al.
        The effect of magnesium sulfate treatment on blood biochemistry and bleeding time in patients with severe preeclampsia.
        J Matern Fetal Neonatal Med. 2010; 23: 399-402
        • Wang W.
        • Xie X.
        • Yuan T.
        • et al.
        Epidemiological trends of maternal hypertensive disorders of pregnancy at the global, regional, and national levels: a population-based study.
        BMC Pregnancy Childbirth. 2021; 21: 364
        • Osungbade K.O.
        • Ige O.K.
        Public health perspectives of preeclampsia in developing countries: implication for health system strengthening.
        J Pregnancy. 2011; 2011: 481095
        • Pratt J.J.
        • Niedle P.S.
        • Vogel J.P.
        • et al.
        Alternative regimens of magnesium sulfate for treatment of preeclampsia and eclampsia: a systematic review of non-randomized studies.
        Acta Obstet Gynecol Scand. 2016; 95: 144-156
        • Brookfield K.
        • Hadiza G.
        • Lihong D.
        • et al.
        Magnesium sulfate pharmacokinetics after intramuscular dosing in women with preeclampsia.
        AJOG Glob Rep. 2021; 1: 100018
        • Walani S.R.
        Global burden of preterm birth.
        Int J Gynaecol Obstet. 2020; 150: 31-33
        • Bain E.
        • Middleton P.
        • Crowther C.A.
        Different magnesium sulphate regimens for neuroprotection of the fetus for women at risk of preterm birth.
        Cochrane Database Syst Rev. 2012; 15: CD009302
        • Brookfield K.F.
        • Vinson A.
        Magnesium sulfate use for fetal neuroprotection.
        Curr Opin Obstet Gynecol. 2019; 31: 110-115
        • Lingam I.
        • Robertson N.J.
        Magnesium as a neuroprotective agent: a review of its use in the fetus, term infant with neonatal encephalopathy, and the adult stroke patient.
        Dev Neurosci. 2018; 40: 1-12
        • Jahnen-Dechent W.
        • Ketteler M.
        Magnesium basics.
        Clin Kidney J. 2012; 5: i3-i14
        • Dan B.
        • Paneth N.
        Making sense of cerebral palsy prevalence in low-income countries.
        Lancet Glob Health. 2017; 5: e1174-e1175
        • Jahan I.
        • Muhit M.
        • Hardianto D.
        • et al.
        Epidemiology of cerebral palsy in low- and middle-income countries: preliminary findings from an international multi-centre cerebral palsy register.
        Dev Med Child Neurol. 2021; 63: 1327-1336
        • Brookfield K.F.
        • Tuel K.
        • Rincon M.
        • et al.
        Alternate dosing protocol for magnesium sulfate in obese women with preeclampsia: a randomized controlled trial.
        Obstet Gynecol. Dec 2020; 136: 1190-1194